Third Generation Sequencing Market Synopsis: 

Third Generation Sequencing Market Size Was Valued at USD 10.10 Billion in 2023, and is Projected to Reach USD 50.57 Billion by 2032, Growing at a CAGR of 19.60 % From 2024-2032. 

The Third Generation Sequencing (TGS) market is defined here as the market that involves the use of latest DNA sequencing technologies that identify and interpret nucleotide sequencing at higher rates at lower costs as compared to the existing techniques. Whereas second-generation sequencing depends only on short read sequent technologies, TGS utilizes longer reads which increases its resolution in identifying different structures in the genome. This market categorizes instruments, consumables, services and its various applications varying from clinical diagnostic, research and use in the filed of personalized medicine.  

There are several factors that drive the growth of the Third Generation Sequencing market and those most technology related, especially the development in long-read sequencing that offers a lot of detail concerning the genetic make up and is especially suitable for complex genomes. Such improvements are making TGS more applicable in research and clinical diagnostics of rare genetic disorders, changes, mutation, and structural variants that are undetectable using other sequencing approaches. The decline of the costs associated with sequencing over time also improves availability to research centers, hospitals, and biotechnology firms. 

The other factor is the growing customer customization whereby treatment is adopted according to genetic make-up of a person. TGS technologies make it possible to achieve more accurate assessment of client’s genotype, thus the ability to direct the treatment more accurately, particularly in cases of cancer and genetic diseases. The large-scale investment in the biotechnology and pharma sector and the patronize by governments to encourage genomic research have led to increased demand of TGS in different clinical applications. 

Third Generation Sequencing Market Trend Analysis: 

Nanopore sequencing owing to its capability of real-time 

  • The emerging trend in Third Generation Sequencing is the rise of nanopore sequencing owing to its capability of real-time, no-enzyme and no-PCR sample preparation sequencing. This has made it possible for field-based applications and is gradually picking up in academics and in clinical research where timely collection of genomic data is important. Further, TGS is being combined with artificial intelligence (AI) and Machine learning (ML) for fine-tuning genetic interpretation of increased precision as well as for automation of monitoring and data analysis for better healthcare results. 

  • Another extraordinary trend is the concern with multi-omics approaches when the sequencing methods are used complemented by transcriptome, proteome, and metabolome. This combined approach results in a better understanding of cellphone biology and is beginning to be applied in pharmacology and personalized medicine. With medical care institutions gradually following the concept of precision medicine, TGS techniques are more widely used to improve the molecular understanding of diseases. 

Employed for diagnosis of rare and complex diseases including genetic disorders and cancer 

  • The biggest market opportunity for the Third Generation Sequencing market is in the clinical diagnostics where the technology is employed for diagnosis of rare and complex diseases including genetic disorders and cancer. The development of non-invasive prenatal testing commonly referred as NIPT and genetic screening R represent new large market for TGS. Further, the improvement of the accuracy and affordability of sequencing also opens the entirely new pathway for the development of routine diagnostic tests based on TGS. 

  • The other promising area is in agriculture and environ metrics – Third Generation Sequencing being now applied to genetic profiling of crops, livestock and habitats. The aforementioned positive effects on food security and environmental awareness regarding microbial communities and plant genomes, when sequenced more effectively, remain a major growth opportunity market. This is due to the recent promotion of sustainable farming and environment preservation farming. 

Third Generation Sequencing Market Segment Analysis: 

Third Generation Sequencing Market Segmented on the basis of Product, Application, End User, and Region.  

By Product, Instruments segment is expected to dominate the market during the forecast period 

  • The Third Generation Sequencing market is divided into three main segments: Instruments Consumables and Services. Equipment are the building blocks of sequencing platforms encompassing machines and related technologies used in sequencing activities. Sequencing reagents and kits mean the reagents, tests kits and other products that are used in the performance of the sequencing tests. Other services range from the array and sequencing services where the companies offer to analyze and interpret the data from the sequencing. These products are useful in many scenarios such as diagnosing patients, as well as for mass population genomics studies. 

By Application, Clinical Diagnostic segment expected to held the largest share  

  • Third Generation Sequencing is applied in various fields and that makes the market associated with this technology to be greatly demanded. Clinical diagnosis entails applying TGS for to identify mutations, diseases, or abnormalities of a patient. TGS is especially useful in drugs discovery because it facilitates fast screening of the genetic markers for potential new drugs. This involves tailor made treatments of diseases through medicine after analyzing an individual’s genetic information through TGS. In R & D, TGS is applied to sequence model organisms and humans as well as in different scientific studies. Finally the agriculture and environmental science industries apply TGS in the areas of crop improvement, pests management, and microbial population research. 

Third Generation Sequencing Market Regional Insights:  

North America is Expected to Dominate the Market Over the Forecast period  

  • Third Generation Sequencing in North America holds the utmost share in the global market and is expected to grow continuously in the near future due to increasing demand for high sequencing technology across the global research, diagnostics, and biotechnology sectors. In particular, the USA has invested much funding from both the government and private sectors in research on genomic. Sequencing vendors, research organizations and healthcare also exist prominently in the region which further contributes to the dominance of this region. Also for North America, the health care system is well developed and regulations provide necessary support for investments in and adoption of new technologies such as TGS. 

  • Additionally, the increased development on the concept on personalized medicine and the precision health in the region, and the rising need for more comprehensive genomic solutions in clinical diagnosis also make the region suitable market for Third Generation Sequencing technologies. North America has also been experiencing a rise in the number of research partnerships between universities and organizations hence driving the market. 

Active Key Players in the Third Generation Sequencing Market: 

  • Illumina (USA) 
  • Pacific Biosciences (USA) 
  • Oxford Nanopore Technologies (UK) 
  • Roche Diagnostics (Switzerland) 
  • Thermo Fisher Scientific (USA) 
  • 10x Genomics (USA) 
  • BGI Genomics (China) 
  • Genomics England (UK) 
  • Qiagen (Germany) 
  • Agilent Technologies (USA) 
  • Other Active Players 

Global Third Generation Sequencing Market 

Base Year: 

2023 

Forecast Period: 

2024-2032 

Historical Data: 

2017 to 2023 

Market Size in 2023: 

USD 10.10 Billion 

Forecast Period 2024-32 CAGR: 

19.60 % 

Market Size in 2032: 

USD 50.57 Billion 

Segments Covered: 

By Product 

  • Instruments 
  • Consumables 
  • Services 

By Application 

  • Clinical Diagnostics 
  • Drug Discovery 
  • Personalized Medicine 
  • Research & Development 
  • Agriculture & Environmental Science 

By End User 

  • Hospitals & Clinics 
  • Pharmaceutical & Biotechnology Companies 
  • Research Institutes & Academia, Contract Research Organizations (CROs) 

By Region 

  • North America (U.S., Canada, Mexico) 
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe) 
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe) 
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC) 
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa) 
  • South America (Brazil, Argentina, Rest of SA) 

Key Market Drivers: 

  • Cost Reductions and Accessibility Improvements 

Key Market Restraints: 

  • Complex Data Analysis Requirements 

Key Opportunities: 

  • Integration with Artificial Intelligence and Machine Learning 

Companies Covered in the report: 

  • Illumina (USA), Pacific Biosciences (USA), Oxford Nanopore Technologies (UK), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (USA), 10x Genomics (USA), BGI Genomics (China), Genomics England (UK), Qiagen (Germany), Agilent Technologies (USA). and Other Active Players. 

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Third Generation Sequencing Market by Application
 4.1 Third Generation Sequencing Market Snapshot and Growth Engine
 4.2 Third Generation Sequencing Market Overview
 4.3 Power Control
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Power Control: Geographic Segmentation Analysis
 4.4 Motor Control
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Motor Control: Geographic Segmentation Analysis
 4.5 Light Dimming
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Light Dimming: Geographic Segmentation Analysis
 4.6 Heater Control
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Heater Control: Geographic Segmentation Analysis
 4.7 Overcurrent Protection
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Overcurrent Protection: Geographic Segmentation Analysis
 4.8 Others
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Others: Geographic Segmentation Analysis

Chapter 5: Third Generation Sequencing Market by End User
 5.1 Third Generation Sequencing Market Snapshot and Growth Engine
 5.2 Third Generation Sequencing Market Overview
 5.3 Industrial
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Industrial: Geographic Segmentation Analysis
 5.4 Automotive
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Automotive: Geographic Segmentation Analysis
 5.5 Consumer Electronics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Consumer Electronics: Geographic Segmentation Analysis
 5.6 Power Generation
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Power Generation: Geographic Segmentation Analysis
 5.7 Oil & Gas
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Oil & Gas: Geographic Segmentation Analysis
 5.8 Telecommunication
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Telecommunication: Geographic Segmentation Analysis
 5.9 Other End-User Industries
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Other End-User Industries: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Third Generation Sequencing Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions  
 6.2 ILLUMINA (USA)
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 PACIFIC BIOSCIENCES (USA)
 6.4 OXFORD NANOPORE TECHNOLOGIES (UK)
 6.5 ROCHE DIAGNOSTICS (SWITZERLAND)
 6.6 THERMO FISHER SCIENTIFIC (USA)
 6.7 10X GENOMICS (USA)
 6.8 BGI GENOMICS (CHINA)
 6.9 GENOMICS ENGLAND (UK)
 6.10 QIAGEN (GERMANY)
 6.11 AGILENT TECHNOLOGIES (USA)
 6.12 OTHER ACTIVE PLAYERS

Chapter 7: Global Third Generation Sequencing Market By Region
 7.1 Overview
7.2. North America Third Generation Sequencing Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Application
  7.2.4.1 Power Control
  7.2.4.2 Motor Control
  7.2.4.3 Light Dimming
  7.2.4.4 Heater Control
  7.2.4.5 Overcurrent Protection
  7.2.4.6 Others
  7.2.5 Historic and Forecasted Market Size By End User
  7.2.5.1 Industrial
  7.2.5.2 Automotive
  7.2.5.3 Consumer Electronics
  7.2.5.4 Power Generation
  7.2.5.5 Oil & Gas
  7.2.5.6 Telecommunication
  7.2.5.7 Other End-User Industries
  7.2.6 Historic and Forecast Market Size by Country
  7.2.6.1 US
  7.2.6.2 Canada
  7.2.6.3 Mexico
7.3. Eastern Europe Third Generation Sequencing Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Application
  7.3.4.1 Power Control
  7.3.4.2 Motor Control
  7.3.4.3 Light Dimming
  7.3.4.4 Heater Control
  7.3.4.5 Overcurrent Protection
  7.3.4.6 Others
  7.3.5 Historic and Forecasted Market Size By End User
  7.3.5.1 Industrial
  7.3.5.2 Automotive
  7.3.5.3 Consumer Electronics
  7.3.5.4 Power Generation
  7.3.5.5 Oil & Gas
  7.3.5.6 Telecommunication
  7.3.5.7 Other End-User Industries
  7.3.6 Historic and Forecast Market Size by Country
  7.3.6.1 Russia
  7.3.6.2 Bulgaria
  7.3.6.3 The Czech Republic
  7.3.6.4 Hungary
  7.3.6.5 Poland
  7.3.6.6 Romania
  7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Third Generation Sequencing Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Application
  7.4.4.1 Power Control
  7.4.4.2 Motor Control
  7.4.4.3 Light Dimming
  7.4.4.4 Heater Control
  7.4.4.5 Overcurrent Protection
  7.4.4.6 Others
  7.4.5 Historic and Forecasted Market Size By End User
  7.4.5.1 Industrial
  7.4.5.2 Automotive
  7.4.5.3 Consumer Electronics
  7.4.5.4 Power Generation
  7.4.5.5 Oil & Gas
  7.4.5.6 Telecommunication
  7.4.5.7 Other End-User Industries
  7.4.6 Historic and Forecast Market Size by Country
  7.4.6.1 Germany
  7.4.6.2 UK
  7.4.6.3 France
  7.4.6.4 The Netherlands
  7.4.6.5 Italy
  7.4.6.6 Spain
  7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Third Generation Sequencing Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Application
  7.5.4.1 Power Control
  7.5.4.2 Motor Control
  7.5.4.3 Light Dimming
  7.5.4.4 Heater Control
  7.5.4.5 Overcurrent Protection
  7.5.4.6 Others
  7.5.5 Historic and Forecasted Market Size By End User
  7.5.5.1 Industrial
  7.5.5.2 Automotive
  7.5.5.3 Consumer Electronics
  7.5.5.4 Power Generation
  7.5.5.5 Oil & Gas
  7.5.5.6 Telecommunication
  7.5.5.7 Other End-User Industries
  7.5.6 Historic and Forecast Market Size by Country
  7.5.6.1 China
  7.5.6.2 India
  7.5.6.3 Japan
  7.5.6.4 South Korea
  7.5.6.5 Malaysia
  7.5.6.6 Thailand
  7.5.6.7 Vietnam
  7.5.6.8 The Philippines
  7.5.6.9 Australia
  7.5.6.10 New Zealand
  7.5.6.11 Rest of APAC
7.6. Middle East & Africa Third Generation Sequencing Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Application
  7.6.4.1 Power Control
  7.6.4.2 Motor Control
  7.6.4.3 Light Dimming
  7.6.4.4 Heater Control
  7.6.4.5 Overcurrent Protection
  7.6.4.6 Others
  7.6.5 Historic and Forecasted Market Size By End User
  7.6.5.1 Industrial
  7.6.5.2 Automotive
  7.6.5.3 Consumer Electronics
  7.6.5.4 Power Generation
  7.6.5.5 Oil & Gas
  7.6.5.6 Telecommunication
  7.6.5.7 Other End-User Industries
  7.6.6 Historic and Forecast Market Size by Country
  7.6.6.1 Turkiye
  7.6.6.2 Bahrain
  7.6.6.3 Kuwait
  7.6.6.4 Saudi Arabia
  7.6.6.5 Qatar
  7.6.6.6 UAE
  7.6.6.7 Israel
  7.6.6.8 South Africa
7.7. South America Third Generation Sequencing Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Application
  7.7.4.1 Power Control
  7.7.4.2 Motor Control
  7.7.4.3 Light Dimming
  7.7.4.4 Heater Control
  7.7.4.5 Overcurrent Protection
  7.7.4.6 Others
  7.7.5 Historic and Forecasted Market Size By End User
  7.7.5.1 Industrial
  7.7.5.2 Automotive
  7.7.5.3 Consumer Electronics
  7.7.5.4 Power Generation
  7.7.5.5 Oil & Gas
  7.7.5.6 Telecommunication
  7.7.5.7 Other End-User Industries
  7.7.6 Historic and Forecast Market Size by Country
  7.7.6.1 Brazil
  7.7.6.2 Argentina
  7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
 

Global Third Generation Sequencing Market 

Base Year: 

2023 

Forecast Period: 

2024-2032 

Historical Data: 

2017 to 2023 

Market Size in 2023: 

USD 10.10 Billion 

Forecast Period 2024-32 CAGR: 

19.60 % 

Market Size in 2032: 

USD 50.57 Billion 

Segments Covered: 

By Product 

  • Instruments 
  • Consumables 
  • Services 

By Application 

  • Clinical Diagnostics 
  • Drug Discovery 
  • Personalized Medicine 
  • Research & Development 
  • Agriculture & Environmental Science 

By End User 

  • Hospitals & Clinics 
  • Pharmaceutical & Biotechnology Companies 
  • Research Institutes & Academia, Contract Research Organizations (CROs) 

By Region 

  • North America (U.S., Canada, Mexico) 
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe) 
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe) 
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC) 
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa) 
  • South America (Brazil, Argentina, Rest of SA) 

Key Market Drivers: 

  • Cost Reductions and Accessibility Improvements 

Key Market Restraints: 

  • Complex Data Analysis Requirements 

Key Opportunities: 

  • Integration with Artificial Intelligence and Machine Learning 

Companies Covered in the report: 

  • Illumina (USA), Pacific Biosciences (USA), Oxford Nanopore Technologies (UK), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (USA), 10x Genomics (USA), BGI Genomics (China), Genomics England (UK), Qiagen (Germany), Agilent Technologies (USA). and Other Active Players. 

Frequently Asked Questions :

What would be the forecast period in the Third Generation Sequencing Market research report?
The forecast period in the Third Generation Sequencing Market research report is 2024-2032.
Who are the key players in the Third Generation Sequencing Market?
Illumina (USA), Pacific Biosciences (USA), Oxford Nanopore Technologies (UK), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (USA), 10x Genomics (USA), BGI Genomics (China), Genomics England (UK), Qiagen (Germany), Agilent Technologies (USA). and Other Active Players.
What are the segments of the Third Generation Sequencing Market?
The Third Generation Sequencing Market is segmented into By Product, By Application, By End User and region. By Product, the market is categorized into Instruments, Consumables, Services. By Application, the market is categorized into Clinical Diagnostics, Drug Discovery, Personalized Medicine, Research & Development, Agriculture & Environmental Science. By End User, the market is categorized into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Institutes & Academia, Contract Research Organizations (CROs). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
What is the Third Generation Sequencing Market?
The Third Generation Sequencing (TGS) market is defined here as the market that involves the use of latest DNA sequencing technologies that identify and interpret nucleotide sequencing at higher rates at lower costs as compared to the existing techniques. Whereas second-generation sequencing depends only on short read sequent technologies, TGS utilizes longer reads which increases its resolution in identifying different structures in the genome. This market categorizes instruments, consumables, services and its various applications varying from clinical diagnostic, research and use in the filed of personalized medicine.
How big is the Third Generation Sequencing Market?
Third Generation Sequencing Market Size Was Valued at USD 10.10 Billion in 2023, and is Projected to Reach USD 50.57 Billion by 2032, Growing at a CAGR of 19.60 % From 2024-2032.